BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1098887)

  • 1. [Effect of slow-release aminophylline on pulmonary function in obstructive respiratory disease(author's transl)].
    Wiessmann KJ
    Dtsch Med Wochenschr; 1975 Sep; 100(36):1781-90. PubMed ID: 1098887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of long-term oral administration of a bronchodilator, a sustained-release aminophylline preparation, on pulmonary function (author's transl)].
    Wiessmann KJ
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2482-6. PubMed ID: 1201724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lung functions and blood levels after parenteral administration of theophylline-ethylenediamine (author's transl)].
    Wiessmann KJ; Schulz HU
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1916-20. PubMed ID: 598301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of an oral aminophylline compound with protracted activity on respiratory resistance and blood gases in obstructive respiratory diseases (author's transl)].
    Dorow P
    Arzneimittelforschung; 1978; 28(5):853-6. PubMed ID: 373776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nitroglycerine in chronic obstructive pulmonary disease (author's transl)].
    Niehues B; Römer CF; Thoma R; Behrenbeck DW; Hilger HH
    Dtsch Med Wochenschr; 1979 May; 104(19):691-6. PubMed ID: 108070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of theophylline-ethylenediamine in obstructive lung disease (author's transl)].
    Brossmann D; Ruf G; Wiessmann KJ
    Dtsch Med Wochenschr; 1980 Mar; 105(12):410-3. PubMed ID: 7363785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of proxyphylline in chronic obstructive pulmonary disease (author's transl)].
    Geisler LS; Thiel H; Förster OB; Rohner HG
    Dtsch Med Wochenschr; 1980 Jun; 105(25):894-7. PubMed ID: 7408664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of slow-release oral aminophylline on circadian variation in airflow obstruction in asthmatics.
    Cole RB; Al-Khader A
    J Int Med Res; 1979; 7 Suppl 1():40-4. PubMed ID: 374163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tolerance and effect of short-term theophylline infusions].
    Schmidt M
    Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminophylline, respiratory muscle strength and exercise tolerance in chronic obstructive airway disease.
    Cooper CB; Davidson AC; Cameron IR
    Bull Eur Physiopathol Respir; 1987; 23(1):15-22. PubMed ID: 3297214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theophylline blood levels after administration of Euphyllin retard (author's transl)].
    Ahrens J
    Dtsch Med Wochenschr; 1977 Apr; 102(13):482-6. PubMed ID: 844428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Propranolol and pindolol in chronic obstructive lung disease (author's transl)].
    Ulmer WT; Lanser K
    Dtsch Med Wochenschr; 1976 Nov; 101(48):1765-8. PubMed ID: 791605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
    Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G
    Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J; Mirtallo JM; Altman M
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic obstructive pulmonary disease with orally administered aminophylline].
    Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Oct; 11(5):265-8, 317-8. PubMed ID: 3233685
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind trial of oral aminophylline (Phyllocontin Continus tablets) in airflow obstruction: preliminary communication.
    Greening AP; Baillie E; Gribbin HR; Pride NB
    J Int Med Res; 1979; 7 Suppl 1():47-51. PubMed ID: 374164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term oxygen treatment (author's transl)].
    Petro W; Konietzko N
    Dtsch Med Wochenschr; 1982 Aug; 107(31-32):1178-81. PubMed ID: 7105994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.